Palabras clave
trombosis
trombocitopenia
Cómo citar
Resumen
La trombosis venosa y la trombocitopenia después de la vacunación con la vacuna COVID-19 transmitida por adenovirus ChAdOx1 nCov-19 (AstraZeneca) se han relacionado con anticuerpos séricos contra el factor plaquetario 4 (PF4)-complejos polianión. Reportamos aquí un caso de síndrome de trombosis con trombocitopenia inducida por esta vacuna. Se presentan los hallazgos de laboratorio e imagen, las decisiones de tratamiento y el resultado de este caso.
Citas
Aladdin Y, Algahtani H, Shirah B. Vaccine-Induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death following the ChAdOx1 nCoV-19 vaccine. J Stroke Cerebrovasc Dis. 2021;30(9):105938.
Al Rawahi B, BaTaher H, Jaffer Z et al. Vaccine-inducedimmune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-A case report. Res Pract Thromb Haemost. 2021;5(6):e12578.
Althaus K, Möller P, Uzun G et al. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica. 2021;106(8):2170-2179.
American Society of Hematology. Thrombosis with thrombocytopenia syndrome (also termed vaccine-induced thrombotic thrombocytopenia). 2021. Accessed April 30, 2021. https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic- thrombocytopenia
Barral M, Arrive L, El Mouhadi-Barnier S et al. Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Med. 2021;47(9):1034-1036.
Bayas A, Menacher M, Christ M et al. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet. 2021;397(10285):e11.
Bersinger S, Lagarde K, Marlu R et al. Using nonheparin anticoagulant to treat a near-fatal case With multiple venous thrombotic lesions during ChAdOx1 nCoV-19 vaccination-related vaccine-induced immune thrombotic thrombocytopenia. Crit Care Med. 2021;49(9):e870-e873.
Blauenfeldt RA, Kristensen SR, Ernstsen SL et al. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J Thromb Haemost. 2021;19(7):1771-1775.
Bourguignon A, Arnold DM, Warkentin TE et al. Adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia. N Engl J Med. 2021;385(8):720-8.
Castelli GP, Pognani C, Sozzi, C et al. Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Crit Care. 2021;25(1):1-2.
MacIntyre CR, Veness B, Berger D, Hamad N, Bari N. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia. Vaccine. 2021 Aug 9;39(34):4784-4787.
Cuker A. Management of the multiple phases of heparin- induced thrombocytopenia. Thromb Haemost. 2016;116(5):835-842.
D’agostino V, Caranci F, Negro A et al. A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. J Pers Med. 2021;11(4):285.
Dhoot R, Kansal A, Handran C et al. Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. Am J Hematol. 2021;96(9):1180-1182.
Gangi A, Mobashwera B, Ganczakowski M et al. Imaging and hematologic findings in thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 (Astra-Zeneca) vaccination. Radiology. 2021:211546.
George G, Friedman KD, Curtis BR et al. Successful treatment of thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26.COV2.S vaccination. Am J Hematol. 2021;96(8):E301-E3E3.
Gras-Champel V, Liabeuf S, Baud M et al. Atypical thrombosis associated with VaxZevria®(AstraZeneca) vaccine: data from the French network of regional pharmacovigilance centres. Therapie. 2021;76(4):369-373.
Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021;384(22):2092-2101.
Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle P, Eichinger S. A prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia following coronavirus-19 vaccination. Research Square. 2021;1-8.
Jamme M, Mosnino E, Hayon J et al. Fatal cerebral venous sinus thrombosis after COVID-19 vaccination. Intensive Care Med. 2021;47(7):790-791.
Jones M, Boisvert A, Landry J et al. Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia. CMAJ. 2021;193(24):E906-EE10.
Mehta PR, Mangion SA, Benger M et al. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination - a report of two UK cases. Brain Behav Immun. 2021; 95:514-517
Mohanty E, Nazir S, Sheppard JAI et al. High-dose intravenous immunoglobulin to treat spontaneous heparin- induced thrombocytopenia syndrome. J Thromb Haemost. 2019;17(5):841-844.
Muster V, Gary T, Raggam RB et al. Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination. Lancet. 2021;397(10287):1842.
Öcal O, Stecher SS, Wildgruber M. Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination. Lancet Gastroenterol Hepatol. 2021;6(8):676.
Oldenburg J, Klamroth R, Langer F et al. Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH. Hamostaseologie. 2021;41(3):184-189.
Schultz NH, Sørvoll IH, Michelsen AE et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021;384(22):2124-2130.
Scully M, Singh D, Lown R et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021;384(23):2202-2211.
Umbrello M, Brena, N Vercelli R et al. Successful treatment of acute spleno-porto-mesenteric vein thrombosis after ChAdOx1 nCoV-19 vaccine. A case report. J Crit Care. 2021;65:72-75.
Vayne C, Rollin J, Gruel Y et al. PF4 Immunoassays in vaccine-induced thrombotic thrombocytopenia. N Engl J Med. 2021;385(4):376-378.
Voysey M, Clemens SAC, Madhi SA et al. Safety and efficacy of the ChAdOx1nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four arandomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111.
Warkentin TE. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review. Expert Rev Hematol. 2019;12(8):685-698.
Zanferrari C, Fanucchi S, Liberato NL et al. Excellent response to high-dose intravenous immunoglobulin in anti-PF4 positive cerebral thrombosis following ofxord-AstraZeneca AZD1222 vaccine. 2021. Updated April 12, 2021. Accessed May 24, 2021. https://www.researchsquare.com/article/rs-399801/v1.
Todo el material publicado en la revista Hematología (versión electrónica y versión impresa), será cedido a la Sociedad Argentina de Hematología. De conformidad con la ley de derecho de autor (ley 11723) se les enviara a los autores de cada trabajo aceptado formulario de cesión de derechos de autor que deberá ser firmado por todos los autores antes de la publicación. Los autores deberán retener una copia del original pues la revista, no acepta responsabilidad por daños o pérdidas del material enviado. Los autores deberán remitir una versión electrónica al correo: revista@sah.org.ar